Header cover image
  • Investing Ideas
  • Nigerian Pharmaceuticals & Biotech Undervalued based on future growth

Nigerian Pharmaceuticals & Biotech Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

May & Baker Nigeria

Market Cap: ₦65.6b

May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.

MAYBAKER

₦38.00

7D

-4.4%

1Y

363.4%